Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer

Mostrar otras versiones (1)

Because there is no effective treatment for late‐stage prostate cancer (PCa) at this moment, identifying novel targets for therapy of advanced PCa is urgently needed. A new network‐based systems biology approach, XDeath, is developed to detect crosstalk of signaling pathways associated with PCa prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhuangzhuang, Cheng, Lijun, Zhang, Qiongsi, Kong, Yifan, He, Daheng, Li, Kunyu, Rea, Matthew, Wang, Jianling, Wang, Ruixin, Liu, Jinghui, Li, Zhiguo, Yuan, Chongli, Liu, Enze, Fondufe‐Mittendorf, Yvonne N., Li, Lang, Han, Tao, Wang, Chi, Liu, Xiaoqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261504/
https://www.ncbi.nlm.nih.gov/pubmed/34051063
http://dx.doi.org/10.1002/advs.202101458

Ejemplares similares

Ejemplares similares